Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer
- PMID: 25936246
- DOI: 10.1016/j.suronc.2015.04.003
Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer
Abstract
Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability. We currently find ourselves in "the next generation", with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate.
Keywords: BRCA1; BRCA2; Breast neoplasm; Genetic predisposition to disease; Genetics; Sequence analysis.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.JAMA. 2006 Mar 22;295(12):1379-88. doi: 10.1001/jama.295.12.1379. JAMA. 2006. PMID: 16551709
-
Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.Eur J Surg Oncol. 2015 May;41(5):641-6. doi: 10.1016/j.ejso.2015.01.021. Epub 2015 Feb 17. Eur J Surg Oncol. 2015. PMID: 25736863
-
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8. Breast Cancer Res Treat. 2004. PMID: 15564800
-
Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.Breast. 2016 Aug;28:136-44. doi: 10.1016/j.breast.2016.05.006. Epub 2016 Jun 16. Breast. 2016. PMID: 27318168 Review.
-
Pitfalls and caveats in BRCA sequencing.Ultrastruct Pathol. 2006 May-Jun;30(3):229-35. doi: 10.1080/01913120500521281. Ultrastruct Pathol. 2006. PMID: 16825125 Review.
Cited by
-
Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort.Cancers (Basel). 2023 Jun 29;15(13):3420. doi: 10.3390/cancers15133420. Cancers (Basel). 2023. PMID: 37444530 Free PMC article.
-
Genome-wide linkage search for cancer susceptibility loci in a cohort of non BRCA1/2 families in Sri Lanka.BMC Res Notes. 2022 Jun 2;15(1):190. doi: 10.1186/s13104-022-06081-5. BMC Res Notes. 2022. PMID: 35655316 Free PMC article.
-
Total RNA nonlinear polarization: towards facile early diagnosis of breast cancer.RSC Adv. 2021 Oct 11;11(53):33319-33325. doi: 10.1039/d1ra05599b. eCollection 2021 Oct 8. RSC Adv. 2021. PMID: 35497529 Free PMC article.
-
A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families.Stat Methods Med Res. 2021 Sep;30(9):2165-2183. doi: 10.1177/09622802211008945. Epub 2021 Jul 7. Stat Methods Med Res. 2021. PMID: 34232831 Free PMC article.
-
Cancer Progress and Priorities: Breast Cancer.Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):822-844. doi: 10.1158/1055-9965.EPI-20-1193. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33947744 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous